BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 28211918)

  • 1. Myotonic dystrophy type 1 patient-derived iPSCs for the investigation of CTG repeat instability.
    Ueki J; Nakamori M; Nakamura M; Nishikawa M; Yoshida Y; Tanaka A; Morizane A; Kamon M; Araki T; Takahashi MP; Watanabe A; Inagaki N; Sakurai H
    Sci Rep; 2017 Feb; 7():42522. PubMed ID: 28211918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Length-dependent CTG·CAG triplet-repeat expansion in myotonic dystrophy patient-derived induced pluripotent stem cells.
    Du J; Campau E; Soragni E; Jespersen C; Gottesfeld JM
    Hum Mol Genet; 2013 Dec; 22(25):5276-87. PubMed ID: 23933738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome Therapy of Myotonic Dystrophy Type 1 iPS Cells for Development of Autologous Stem Cell Therapy.
    Gao Y; Guo X; Santostefano K; Wang Y; Reid T; Zeng D; Terada N; Ashizawa T; Xia G
    Mol Ther; 2016 Aug; 24(8):1378-87. PubMed ID: 27203440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variant CCG and GGC repeats within the CTG expansion dramatically modify mutational dynamics and likely contribute toward unusual symptoms in some myotonic dystrophy type 1 patients.
    Braida C; Stefanatos RK; Adam B; Mahajan N; Smeets HJ; Niel F; Goizet C; Arveiler B; Koenig M; Lagier-Tourenne C; Mandel JL; Faber CG; de Die-Smulders CE; Spaans F; Monckton DG
    Hum Mol Genet; 2010 Apr; 19(8):1399-412. PubMed ID: 20080938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoblastoid cell lines derived from iPSCs of a myotonic dystrophy type 1 patient carrying 700 CTG repeats (CBRCULi007-A) and a control (CBRCULi006-A).
    Chahine M; Jauvin D; Pierre M; Puymirat J; Boutjdir M
    Stem Cell Res; 2023 Sep; 71():103148. PubMed ID: 37352653
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Visconti VV; Macrì E; D'Apice MR; Centofanti F; Massa R; Novelli G; Botta A
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Respiratory failure in a mouse model of myotonic dystrophy does not correlate with the CTG repeat length.
    Panaite PA; Kuntzer T; Gourdon G; Barakat-Walter I
    Respir Physiol Neurobiol; 2013 Oct; 189(1):22-6. PubMed ID: 23811192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of the Complex Relationship between Epigenetics Markers, CTG Repeat Instability and Symptoms in Myotonic Dystrophy Type 1.
    de Pontual L; Tomé S
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient CRISPR/Cas9-mediated editing of trinucleotide repeat expansion in myotonic dystrophy patient-derived iPS and myogenic cells.
    Dastidar S; Ardui S; Singh K; Majumdar D; Nair N; Fu Y; Reyon D; Samara E; Gerli MFM; Klein AF; De Schrijver W; Tipanee J; Seneca S; Tulalamba W; Wang H; Chai YC; In't Veld P; Furling D; Tedesco FS; Vermeesch JR; Joung JK; Chuah MK; VandenDriessche T
    Nucleic Acids Res; 2018 Sep; 46(16):8275-8298. PubMed ID: 29947794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Huntington's and myotonic dystrophy hESCs: down-regulated trinucleotide repeat instability and mismatch repair machinery expression upon differentiation.
    Seriola A; Spits C; Simard JP; Hilven P; Haentjens P; Pearson CE; Sermon K
    Hum Mol Genet; 2011 Jan; 20(1):176-85. PubMed ID: 20935170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MSH2 knock-down shows CTG repeat stability and concomitant upstream demethylation at the DMPK locus in myotonic dystrophy type 1 human embryonic stem cells.
    Franck S; Barbé L; Ardui S; De Vlaeminck Y; Allemeersch J; Dziedzicka D; Spits C; Vanroye F; Hilven P; Duqué G; Vermeesch JR; Gheldof A; Sermon K
    Hum Mol Genet; 2021 Jan; 29(21):3566-3577. PubMed ID: 33242073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphoblastoids cell lines - Derived iPSC line from a 26-year-old myotonic dystrophy type 1 patient carrying (CTG)
    Martineau L; Racine V; Benichou SA; Puymirat J
    Stem Cell Res; 2018 Jan; 26():103-106. PubMed ID: 29274549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 250 CTG repeats in DMPK is a threshold for correlation of expansion size and age at onset of juvenile-adult DM1.
    Savić D; Rakocvic-Stojanovic V; Keckarevic D; Culjkovic B; Stojkovic O; Mladenovic J; Todorovic S; Apostolski S; Romac S
    Hum Mutat; 2002 Feb; 19(2):131-9. PubMed ID: 11793472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic expansion behaviour of the (CTG)n repeat in myotonic dystrophy knock-in mice is differentially affected by Msh3 and Msh6 mismatch-repair proteins.
    van den Broek WJ; Nelen MR; Wansink DG; Coerwinkel MM; te Riele H; Groenen PJ; Wieringa B
    Hum Mol Genet; 2002 Jan; 11(2):191-8. PubMed ID: 11809728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of triplet repeat expansion on chromatin structure and expression of DMPK and neighboring genes, SIX5 and DMWD, in myotonic dystrophy.
    Frisch R; Singleton KR; Moses PA; Gonzalez IL; Carango P; Marks HG; Funanage VL
    Mol Genet Metab; 2001; 74(1-2):281-91. PubMed ID: 11592825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intergenerational instability of the expanded CTG repeat in the DMPK gene: studies in human gametes and preimplantation embryos.
    De Temmerman N; Sermon K; Seneca S; De Rycke M; Hilven P; Lissens W; Van Steirteghem A; Liebaers I
    Am J Hum Genet; 2004 Aug; 75(2):325-9. PubMed ID: 15185171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CTG repeat expansion size correlates with the splicing defects observed in muscles from myotonic dystrophy type 1 patients.
    Botta A; Rinaldi F; Catalli C; Vergani L; Bonifazi E; Romeo V; Loro E; Viola A; Angelini C; Novelli G
    J Med Genet; 2008 Oct; 45(10):639-46. PubMed ID: 18611984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Instability in the transmission of the myotonic dystrophy CTG repeat in human oocytes and preimplantation embryos.
    Dean NL; Tan SL; Ao A
    Fertil Steril; 2006 Jul; 86(1):98-105. PubMed ID: 16716318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Genome Editing for Myotonic Dystrophy Type 1 Using CRISPR/Cas9.
    Wang Y; Hao L; Wang H; Santostefano K; Thapa A; Cleary J; Li H; Guo X; Terada N; Ashizawa T; Xia G
    Mol Ther; 2018 Nov; 26(11):2617-2630. PubMed ID: 30274788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and clinical characteristics of myotonic dystrophy type 1 in koreans.
    Kim SY; Kim JY; Kim GP; Sung JJ; Lim KS; Lee KW; Chae JH; Hong YH; Seong MW; Park SS
    Korean J Lab Med; 2008 Dec; 28(6):483-92. PubMed ID: 19127114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.